CN101152360A - Traditional Chinese medicine for treating adverse effect of mammary cancer endocrine - Google Patents

Traditional Chinese medicine for treating adverse effect of mammary cancer endocrine Download PDF

Info

Publication number
CN101152360A
CN101152360A CNA2007101326022A CN200710132602A CN101152360A CN 101152360 A CN101152360 A CN 101152360A CN A2007101326022 A CNA2007101326022 A CN A2007101326022A CN 200710132602 A CN200710132602 A CN 200710132602A CN 101152360 A CN101152360 A CN 101152360A
Authority
CN
China
Prior art keywords
grams
medicine
mammary cancer
patient
prescription
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007101326022A
Other languages
Chinese (zh)
Inventor
尹克华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNA2007101326022A priority Critical patent/CN101152360A/en
Publication of CN101152360A publication Critical patent/CN101152360A/en
Pending legal-status Critical Current

Links

Abstract

A Chinese medicine for treating adverse internal secretion of mammary cancer pertains to a Chinese medicine for treating mammary cancer. The components contain: 20g of eclipta, 15g of grossy privet fruit, 15g of motherwort, 6g of curculigo rhizone and 6g of epimedium powder. The invention has the auxiliary prescriptions that for the patient with dry pudendum, 12g of dittany bark and 10g of glabrous greenbrier rhizome are added; for the patient with hectic fever and vexation, 6g of radix bupleuri, 10g of tree peony bark and 20g of fried jujube kernel are added; for the patient with hyperhidrosis, 30g of nacre and 12g of cornus dogwood fruit are added. The dosage materials in the prescription are all made from natural traditional Chinese herbal medicines by the traditional processing method. The materials can be easily gotten; the prescription and the preparation method are simple; the expense for preparing the medicine is low. The compatibility of the traditional Chinese herbal medicines is simple; the medicines used in the medicine prescription are all natural herbal medicines which can be conveniently gotten and used; the manufacturing method is simple; the curative effect after being taken is good; the medicine price is cheap, and the medicine is especially fit for people who live at the remote small villages away from villages and towns to use. The treatment expense for the patient with the disease of the adverse internal secretion of mammary cancer is low, which solves the treatment problem, which is caused by low family income, poor living and lack of local medical treatment condition.

Description

The Chinese medicine of treatment adverse effect of mammary cancer endocrine
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of breast carcinoma, particularly a kind of Chinese medicine for the treatment of adverse effect of mammary cancer endocrine.
Background technology
Primary disease is one of modal malignant tumor of women, many and positive QI-insufficiency, and internal injury caused by excess of seven emotions, the pent-up of liver spleen, Chong and Ren channel disorder is relevant, and clinical in from the beginning of lump in breast, quality is hard, and what push away does not move, and the back shape of bursting is characteristics like general lotus, cauliflower.
At present, when people's paralysis has the adverse effect of mammary cancer endocrine disease, in the flourishing city of medical condition, people are hospital treatments, generally all be to use Western medicine or have an injection and treat, and in the small towns, more particularly away from the small towns, outlying village is when people's paralysis has the disease of adverse effect of mammary cancer endocrine, because family income is low, living in penury, the locality lacks medical condition, needs expensive travelling expenses to go to the flourishing city of medical condition to go to seek medical advice if want to cure the disease, the medical expense of hospital and medical expenses costliness in addition, people's treatment of often not going sick, the recovery from illness of giving free rein to, therefore some patient has incured loss through delay treatment opportunity.
Summary of the invention
The objective of the invention is to provide a kind of: the Chinese medicine of the treatment adverse effect of mammary cancer endocrine that expense is cheap.
The technical scheme that solves its technical problem employing is: form: Herba Ecliptae 20 grams, and Fructus Ligustri Lucidi, each 15 gram of Herba Leonuri, Rhizoma Curculiginis, Herba Epimedii be 6 grams respectively; Auxiliary prescription: the dry and astringent person of pudendum adds Cortex Dictamni 12 grams, Rhizoma Smilacis Glabrae 10 grams; Vexed hectic fever person adds Radix Bupleuri 6 grams, Cortex Moutan 10 grams, Semen Ziziphi Spinosae (parched) 20 grams; Hyperhidrosis person adds Concha Margaritifera 30 grams, Fructus Corni 12 grams.
Beneficial effect: owing to adopted such scheme, the material that makes up a prescription in the prescription all uses natural Chinese herbal medicines, adds that then traditional concocting method is made, material is easily got, prescription and preparation method are simple, and preparation medicine expense is cheap, has reached purpose of the present invention.This Chinese herbal medicine compatibility is simple, employed medicine uses natural herbal fully in the pharmaceutical formulation, it is convenient to get, use, and manufacture method is simple, and it is good to take therapeutic effect, drug price is cheap, can adapt to the people that live in away from small towns, outlying village especially and use, have people's medical expense of adverse effect of mammary cancer endocrine disease cheap, solve because family income is low to paralysis, living in penury, locality lack the problem that medical condition is cured the disease.
This Chinese herbal medicine is a prescription handed down from one's ancestors, the untoward reaction of mainly for treating mammary gland cancer endocrine therapy.Usage: be decocted in water for oral dose, 1 dose of every day, 30 doses is 1 course of treatment.Use this prescription to treat adverse effect of mammary cancer endocrine patient 256 examples, wherein use cure 87 examples a course of treatment, account for 34%; Use cure 93 examples two courses of treatment, account for 36%; Use cure 51 examples three above courses of treatment, account for 20%; Disease controlling 24 examples account for 9%; Readily good therapeutic effect 2 examples account for 1%, and obvious to adverse effect of mammary cancer endocrine disease cured rate effect, the patient of readily good therapeutic effect only accounts for 1%, and paralysis person takes in the therapeutic process of this prescription, does not produce untoward reaction.
The specific embodiment
Embodiment 1: form: Herba Ecliptae 20 grams, Fructus Ligustri Lucidi, each 15 gram of Herba Leonuri, Rhizoma Curculiginis, each 6 gram of Herba Epimedii; Auxiliary prescription: the dry and astringent person of pudendum adds Cortex Dictamni 12 grams, Rhizoma Smilacis Glabrae 10 grams; Vexed hectic fever person adds Radix Bupleuri 6 grams, Cortex Moutan 10 grams, Semen Ziziphi Spinosae (parched) 20 grams; Hyperhidrosis person adds Concha Margaritifera 30 grams, Fructus Corni 12 grams.

Claims (1)

1. a Chinese medicine for the treatment of adverse effect of mammary cancer endocrine is characterized in that: form: Herba Ecliptae 20 grams, Fructus Ligustri Lucidi, each 15 gram of Herba Leonuri, Rhizoma Curculiginis, each 6 gram of Herba Epimedii; Auxiliary prescription: the dry and astringent person of pudendum adds Cortex Dictamni 12 grams, Rhizoma Smilacis Glabrae 10 grams; Vexed hectic fever person adds Radix Bupleuri 6 grams, Cortex Moutan 10 grams, Semen Ziziphi Spinosae (parched) 20 grams; Hyperhidrosis person adds Concha Margaritifera 30 grams, Fructus Corni 12 grams.
CNA2007101326022A 2007-09-15 2007-09-15 Traditional Chinese medicine for treating adverse effect of mammary cancer endocrine Pending CN101152360A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2007101326022A CN101152360A (en) 2007-09-15 2007-09-15 Traditional Chinese medicine for treating adverse effect of mammary cancer endocrine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2007101326022A CN101152360A (en) 2007-09-15 2007-09-15 Traditional Chinese medicine for treating adverse effect of mammary cancer endocrine

Publications (1)

Publication Number Publication Date
CN101152360A true CN101152360A (en) 2008-04-02

Family

ID=39254379

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007101326022A Pending CN101152360A (en) 2007-09-15 2007-09-15 Traditional Chinese medicine for treating adverse effect of mammary cancer endocrine

Country Status (1)

Country Link
CN (1) CN101152360A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101703658B (en) * 2009-10-20 2012-10-03 南京荣世医药科技有限公司 Composition for treating hyperplasia of mammary glands and preparation method thereof
CN103623226A (en) * 2013-11-28 2014-03-12 王真真 Traditional Chinese medicinal composition for treating hyperplasia of mammary glands

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101703658B (en) * 2009-10-20 2012-10-03 南京荣世医药科技有限公司 Composition for treating hyperplasia of mammary glands and preparation method thereof
CN103623226A (en) * 2013-11-28 2014-03-12 王真真 Traditional Chinese medicinal composition for treating hyperplasia of mammary glands
CN103623226B (en) * 2013-11-28 2015-10-07 王志 A kind of Chinese medicine composition for the treatment of cyclomastopathy

Similar Documents

Publication Publication Date Title
CN101152433A (en) Traditional Chinese medicine for treating chemotherapy leukocytopenia after mammary cancer operation
CN101152535A (en) Traditional Chinese medicine for treating subacute thyroiditis
CN101129862A (en) Traditional Chinese medicine for treating acute renal glomerulus nephritis
CN101152331A (en) Traditional Chinese medicine for treating Qi asthenia type hemorrhoid hemorrhage
CN101152518A (en) Traditional Chinese medicine for treating chemotherapy adverse effect after mammary cancer operation
CN101152282A (en) Traditional Chinese medicine for treating tumefaction of membrum superius after mammary cancer operation
CN101129945A (en) Traditional Chinese medicine for treating diffuse liver cancer
CN101164573A (en) Traditional Chinese medicine for treating cold stagnation infantile hernia
CN101129970A (en) Traditional Chinese medicine for treating metaphase and advanced liver cancer
CN101152354A (en) Traditional Chinese medicine for treating acute dacryocystitis
CN101152299A (en) Traditional Chinese medicine for treating goiter and tumor
CN101167932A (en) Traditional Chinese medicine for treating chronic hepatitis B
CN101129967A (en) Traditional Chinese medicine for treating diabetes diarrhea
CN101130052A (en) Traditional Chinese medicine for treating post partum paralysis
CN101152360A (en) Traditional Chinese medicine for treating adverse effect of mammary cancer endocrine
CN101152326A (en) Traditional Chinese medicine for treating relapse herpesvirus keratitis
CN101152313A (en) Traditional Chinese medicine for treating summer dermatitis
CN101837111A (en) Medicament for curing proliferation of mammary glands and preparation method thereof
CN101129742A (en) Traditional Chinese medicine for treating rheumatoid arthritis in active stage
CN101130002A (en) Traditional Chinese medicine for treating lesion before stomach cancer
CN101129707A (en) Traditional Chinese medicine for treating chronic nephritis
CN101143182A (en) Traditional Chinese medicine for treating alcoholic cirrhosis
CN101143205A (en) Traditional Chinese medicine for treating qi deficiency fever
CN101152410A (en) Traditional Chinese medicine for treating alopecia
CN101129804A (en) Traditional Chinese medicine for treating primary liver cancer

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20080402